.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
Dr. Zodiak's Moonrock concentrated 53.84% of September 2026 sales in Flower with a -52.05% year-over-year decline and a -14.16% month-over-month slide, while Vapor Pens held 28.07% share with sharper contractions of -60.03% YoY and -27.72% MoM; in contrast, Pre-Roll grew 44.10% YoY and 10.86% MoM to 18.09% share. Despite a -20.47% YoY drop in average price to $30.53, category exposure remains weighted to segments with steeper YoY declines, and the Vapor Pens rank at 54 in New Jersey suggests weaker relative pull inside the top category, implying that mix is amplifying the -48.73% brand-level YoY contraction even as the 24‑month sales change is +88.12%.
The reallocation signal is that Pre-Roll is the only growth engine, expanding its share to 18.09% while the two larger bases contracted by -52.05% and -60.03% YoY, which—combined with a -27.72% MoM decline in Vapor Pens and a -14.16% MoM in Flower—indicates the brand’s positioning is tilting away from high-price inhalables toward lower-priced, velocity-driven units. With Vapor Pens still the top category by positioning yet ranked 54 in New Jersey and carrying a 48.22 average price versus Flower at 29.30, the current mix points to margin pressure and a need to lean into Pre-Roll’s 10.86% MoM momentum while ring-fencing share loss in the two legacy pillars, implying that near-term stabilization depends on converting Pre-Roll gains into a higher overall share while preventing further rank slippage in Vapor Pens.
Competitive Landscape
Dr. Zodiak's Moonrock sits at rank #54 in New Jersey Vapor Pens in September 2026, sliding 4 positions from #50 in June 2026 while also sitting 4 ranks below its peak position of #50; the absence of a year-over-year rank baseline prevents a direct YoY comparison, but the quarter-over-quarter decline indicates erosion versus prior months. In the same period, Fernway holds #1 after rising from #2 year over year with +19.2% YoY sales growth, while Select sits at #2 after falling from #1 with -24.0% YoY sales, a spread that underscores tightening share at the top even as mid-pack ranks soften; additionally, #3 Legend and #4 Simply Herb each posted double-digit YoY sales declines of -16.4% and -14.6%, respectively, yet still out-rank Dr. Zodiak's Moonrock by 50+ positions, pointing to a gap driven more by distribution or velocity than category contraction. The pattern implies that Dr. Zodiak's Moonrock’s slide from #50 to #54 amid top-tier reshuffling positions it at risk of further rank attrition unless it closes execution gaps that outweigh general category headwinds.
Notable Products
Lion Hart Moonrocks (3.5g) posted the standout move with a 327.6% month-over-month surge to rank 1, while Fuzzy Wuzziez (3.5g) slipped 12.1% at rank 3. Bobby Blue Moonrocks (3.5g) declined 8.7% at rank 2, and Razzle Dazzle Moonrocks (3.5g) fell 25.3% at rank 4. Four of the top ten are Flower SKUs concentrated in 3.5g Moonrocks, and the sharp split between a triple-digit gainer at the top and double-digit decliners below implies the lineup is pivoting toward a single hero strain driving share while legacy Moonrocks require refresh or pruning.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
